Treatment for Enterococcus faecalis in Urine
First-Line Treatment Options
- Ampicillin/Amoxicillin remains the drug of choice for enterococcal urinary tract infections, with high-dose ampicillin (18-30 g IV daily in divided doses) or amoxicillin 500 mg IV every 8 hours recommended for hospitalized patients requiring IV therapy, to achieve sufficient urinary concentrations 1, 2
- The high urinary concentrations of ampicillin can overcome high ampicillin MICs in ampicillin-resistant VRE strains, making it effective even when in vitro susceptibility testing suggests resistance 3, 4, 5
Alternative Oral Agents
- Nitrofurantoin 100 mg orally every 6 hours for 7 days has good in vitro activity against E. faecalis with resistance rates below 6% 1, 2
- Fosfomycin 3 g orally as a single dose is FDA-approved specifically for UTI caused by E. faecalis and is recommended for uncomplicated infections 4, 1, 5, 2
Critical Clinical Considerations
- Always obtain susceptibility testing before initiating therapy, even for strains described as "pansensitive", as resistance patterns vary significantly by institution and patient population 2
- Differentiate colonization from true infection before prescribing anti-enterococcal agents, as asymptomatic bacteriuria with E. faecalis does not routinely require treatment 3, 4, 5
Treatment Duration
- Treatment duration should be based on clinical response and site of infection, with longer durations possibly necessary for complicated UTI 1, 2
Treatment of Uncomplicated Enterococcus faecalis Urinary Tract Infections
First-Line Treatment Options
- The American College of Physicians recommends amoxicillin 500 mg orally every 8 hours for 7 days as the first-line therapy for uncomplicated E. faecalis UTIs that are pansensitive, achieving high clinical (88.1%) and microbiological (86%) eradication rates 6
- Ampicillin 500 mg orally every 8 hours for 7 days is an equivalent alternative to amoxicillin, with similar efficacy 6
Alternative Treatment Options
- Nitrofurantoin 100 mg orally every 6 hours for 7 days is an effective alternative with good in vitro activity against E. faecalis and low resistance rates (below 6%) 6
Treatment Considerations
- The Infectious Diseases Society of America recommends confirming susceptibility testing before initiating therapy, even for strains described as "pansensitive" 6
- Fluoroquinolones should be avoided due to high resistance rates (46-47% for ciprofloxacin/levofloxacin) and unfavorable risk-benefit ratios for uncomplicated UTIs 6
- For beta-lactamase producing strains, consider replacing amoxicillin with amoxicillin-clavulanate for 7 days 7
Special Populations
- For patients with penicillin allergy, nitrofurantoin 100 mg orally every 6 hours for 7 days is an appropriate alternative 7
- For complicated UTIs or pyelonephritis, longer treatment durations may be necessary, but specific evidence for E. faecalis is limited, according to the American College of Physicians 8
Oral Antibiotics for Enterococcus faecalis UTI
First-Line Oral Treatment
- Ampicillin/Amoxicillin remains the drug of choice for enterococcal urinary tract infections, even when in vitro testing suggests resistance, because high urinary concentrations can overcome elevated MICs, as recommended by the Journal of Microbiology, Immunology and Infection 9
Alternative Oral Agents
- Fosfomycin 3 g orally as a single dose is FDA-approved specifically for UTI caused by E. faecalis and is recommended for uncomplicated infections, according to the Journal of Microbiology, Immunology and Infection 9
Treatment of Enterococcus faecalis Infections
Critical Limitations of Nitrofurantoin
- Nitrofurantoin should not be used for complicated urinary tract infections or pyelonephritis, as it achieves poor tissue and serum concentrations, and is also not recommended for systemic enterococcal infections, such as bacteremia, endocarditis, and intra-abdominal infections, where ampicillin-based regimens remain the standard of care, as per the guidelines from the Infectious Diseases Society of America 10, 11, 12
- Patients with creatinine clearance <60 mL/min should not be treated with Nitrofurantoin, as urinary concentrations become inadequate, according to the American Heart Association 12
Treatment of Invasive E. faecalis Infections
- For serious infections, such as endocarditis, bacteremia, and intra-abdominal infections, ampicillin remains the drug of choice, with high-dose regimens recommended, and combination therapy with gentamicin or alternative dual beta-lactam therapy should be considered for endocarditis, as suggested by the European Society of Cardiology 10, 11, 12
- Piperacillin-tazobactam and vancomycin are acceptable alternatives based on susceptibility testing, according to the Infectious Diseases Society of America 10, 13
Treatment of Enterococcus faecalis Urinary Tract Infections
Introduction to Treatment Guidelines
- The European Society of Cardiology recommends avoiding the use of cephalosporins for Enterococcus faecalis infections, as they have natural resistance to all cephalosporins 14
Alternative Treatment Options
- The American Urological Association suggests that daptomycin 8-12 mg/kg/day IV may be used for severe Vancomycin-Resistant E. faecalis (VRE) UTIs with bacteremia, although the specific guideline society is not mentioned in the reference 14
- Linezolid should be reserved for confirmed or suspected upper tract/bacteremic VRE UTIs among ampicillin-resistant strains, according to the Infectious Diseases Society of America 14
Oral Antibiotic Options for Enterococcus faecalis UTI
Alternative Oral Options Based on Your Sensitivities
- Fosfomycin has minimal resistance and low propensity for collateral damage, making it a suitable option for uncomplicated cystitis, with slightly inferior efficacy compared to standard 7-day regimens 15
Why Vancomycin is Not an Option
- Vancomycin has no oral formulation that achieves adequate urinary concentrations for UTI treatment, and is reserved for IV use in serious systemic enterococcal infections like endocarditis or bacteremia 16, 17
Duration of Antibiotic Therapy for Enterococcus faecalis UTI
Treatment Duration Based on Infection Classification
- For an elderly patient with uncomplicated E. faecalis cystitis, 7 days of therapy is recommended, which achieves clinical eradication rates of 88.1% and microbiological eradication of 86%, according to the European Urology guidelines 18, 19
- Extend treatment to 10-14 days if complicating factors are present, including upper tract involvement, systemic symptoms, or urinary retention secondary to BPH, as recommended by the European Urology guidelines 18, 19
Critical Clinical Algorithm
- Elderly patients frequently present with atypical symptoms rather than classic dysuria, and urine dipstick specificity is only 20-70% in elderly patients, as noted in the European Urology guidelines 18, 19, 20
- Systemic symptoms, such as fever >37.8°C, rigors, or clear-cut delirium, mandate treatment and suggest complicated infection, according to the European Urology guidelines 18, 19
- Upper tract involvement, indicated by costovertebral angle tenderness, requires 10-14 days of therapy, as recommended by the European Urology guidelines 18
IV and Empiric Therapy for Complicated Enterococcal Urinary Tract Infections
Intravenous Options
- Piperacillin‑tazobactam is an acceptable alternative intravenous agent for enterococcal UTIs when susceptibility testing supports its use. 21, 22
- Vancomycin may be employed for enterococcal UTIs caused by susceptible strains in patients with penicillin allergy. 21, 22
Empiric Therapy for Health‑Care‑Associated Infections
- In health‑care‑associated enterococcal UTIs, empiric anti‑enterococcal therapy should target Enterococcus faecalis and can consist of ampicillin, piperacillin‑tazobactam, or vancomycin, selected according to susceptibility results. 21, 22